CDMO means customized development and manufacturing in the pharmaceutical field, which is a new type of R&D and manufacturing outsourcing model. The customized R&D and production of pharmaceutical CDMO includes clinical stage and commercialization stage, which generally starts from clinical stage I or II to provide intermediates required for synthesis of new drugs to domestic and foreign customers, and then deeply binds with the customers in the stage of listing review and approval and commercialization production. Technology development services, as the front-end extension of the industry chain of CDMO business, include the discovery and synthesis of new drug compounds, as well as various pre-process research and development services. Pharmaceutical CDMO is the in-depth integration of the entire industry chain from preclinical research, clinical trial to product production, providing innovative process development and production services for enterprises, and replacing simple production capacity output with high value-added technology output. To learn more about CDMO, we recommend consulting professionals.